Researchers have uncovered a previously unrecognized pathway linking lung tumor genetics, diet, and the nervous system that drives cancer-associated cachexia, according to a new study in mice.

A common subtype of lung cancer was found to drive cachexia through nerve signaling involving PGE2. The discovery could lead to new treatments to reduce cancer-related muscle and fat loss.

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs ...

Cachexia, defined as a loss of body weight, fat, and muscle mass that occurs in patients with chronic diseases, including cancer, remains a notable clinical challenge. With limited viable treatment ...

Los Angeles, CA – August 14, 2025 – The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a ...

Histopathological patterns of breast cancer at diagnosis among patients in the Federal Capital Territory, Abuja: Findings from the Network for Oncology Research in Sub-Saharan Africa (NORA) study.

Trial will evaluate visugromab’s potential to reverse cancer-associated weight loss and muscle wasting by targeting GDF-15 in patients with advanced solid tumors Fourth Phase 2b study of visugromab ...

Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF- B signaling and oxidative stress In a recent study, researchers demonstrated that Z526, a novel ...